Press releases
- Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
- Haemonetics Announces Proposed Convertible Senior Notes Offering
- Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical
More ▼
Key statistics
On Thursday, Haemonetics Corp (HAZ:DUS) closed at 81.00, 8.72% above its 52-week low of 74.50, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 81.50 |
---|---|
High | 81.50 |
Low | 81.00 |
Bid | 80.50 |
Offer | 83.50 |
Previous close | 80.50 |
Average volume | 15.80 |
---|---|
Shares outstanding | 50.79m |
Free float | 50.42m |
P/E (TTM) | 39.38 |
Market cap | 4.58bn USD |
EPS (TTM) | 2.29 USD |
Data delayed at least 15 minutes, as of May 23 2024 18:31 BST.
More ▼